Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia

Background: The role of community pharmacists in disease state management has been mooted for some years. Despite a number of trials of disease state management services, there is scant literature into the engagement of, and with, pharmacists in such trials. This paper reports pharmacists’ feedback...

Full description

Bibliographic Details
Main Authors: Emmerton, Lynne, Smith, L., LeMay, K., Krass, I., Saini, B., Bosnic-Anticevich, S., Reddel, H., Burton, D., Stewart, Kay, Armour, C.
Format: Journal Article
Published: BioMed Central 2012
Online Access:http://hdl.handle.net/20.500.11937/33002
_version_ 1848753824131448832
author Emmerton, Lynne
Smith, L.
LeMay, K.
Krass, I.
Saini, B.
Bosnic-Anticevich, S.
Reddel, H.
Burton, D.
Stewart, Kay
Armour, C.
author_facet Emmerton, Lynne
Smith, L.
LeMay, K.
Krass, I.
Saini, B.
Bosnic-Anticevich, S.
Reddel, H.
Burton, D.
Stewart, Kay
Armour, C.
author_sort Emmerton, Lynne
building Curtin Institutional Repository
collection Online Access
description Background: The role of community pharmacists in disease state management has been mooted for some years. Despite a number of trials of disease state management services, there is scant literature into the engagement of, and with, pharmacists in such trials. This paper reports pharmacists’ feedback as providers of a Pharmacy Asthma Management Service (PAMS), a trial coordinated across four academic research centres in Australia in 2009. We also propose recommendations for optimal involvement of pharmacists in academic research. Methods: Feedback about the pharmacists’ experiences was sought via their participation in either a focus group or telephone interview (for those unable to attend their scheduled focus group) at one of three time points. A semi-structured interview guide focused discussion on the pharmacists’ training to provide the asthma service, their interactions with health professionals and patients as per the service protocol, and the future for this type of service. Focus groups were facilitated by two researchers, and the individual interviews were shared between three researchers, with data transcribed verbatim and analysed manually.Results: Of 93 pharmacists who provided the PAMS, 25 were involved in a focus group and seven via telephone interview. All pharmacists approached agreed to provide feedback. In general, the pharmacists engaged with both the service and research components, and embraced their roles as innovators in the trial of a new service. Some experienced challenges in the recruitment of patients into the service and the amount of research-related documentation, and collaborative patient-centred relationships with GPs require further attention. Specific service components, such as the spirometry, were well received by the pharmacists and their patients. Professional rewards included satisfaction from their enhanced practice, and pharmacists largely envisaged a future for the service. Conclusions :The PAMS provided pharmacists an opportunity to become involved in an innovative service delivery model, supported by the researchers, yet trained and empowered to implement the clinical service throughout the trial period and beyond. The balance between support and independence appeared crucial in the pharmacists’ engagement with the trial. Their feedback was overwhelmingly positive, while useful suggestions were identified for future academic trials.
first_indexed 2025-11-14T08:30:39Z
format Journal Article
id curtin-20.500.11937-33002
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:30:39Z
publishDate 2012
publisher BioMed Central
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-330022017-09-13T15:55:51Z Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia Emmerton, Lynne Smith, L. LeMay, K. Krass, I. Saini, B. Bosnic-Anticevich, S. Reddel, H. Burton, D. Stewart, Kay Armour, C. Background: The role of community pharmacists in disease state management has been mooted for some years. Despite a number of trials of disease state management services, there is scant literature into the engagement of, and with, pharmacists in such trials. This paper reports pharmacists’ feedback as providers of a Pharmacy Asthma Management Service (PAMS), a trial coordinated across four academic research centres in Australia in 2009. We also propose recommendations for optimal involvement of pharmacists in academic research. Methods: Feedback about the pharmacists’ experiences was sought via their participation in either a focus group or telephone interview (for those unable to attend their scheduled focus group) at one of three time points. A semi-structured interview guide focused discussion on the pharmacists’ training to provide the asthma service, their interactions with health professionals and patients as per the service protocol, and the future for this type of service. Focus groups were facilitated by two researchers, and the individual interviews were shared between three researchers, with data transcribed verbatim and analysed manually.Results: Of 93 pharmacists who provided the PAMS, 25 were involved in a focus group and seven via telephone interview. All pharmacists approached agreed to provide feedback. In general, the pharmacists engaged with both the service and research components, and embraced their roles as innovators in the trial of a new service. Some experienced challenges in the recruitment of patients into the service and the amount of research-related documentation, and collaborative patient-centred relationships with GPs require further attention. Specific service components, such as the spirometry, were well received by the pharmacists and their patients. Professional rewards included satisfaction from their enhanced practice, and pharmacists largely envisaged a future for the service. Conclusions :The PAMS provided pharmacists an opportunity to become involved in an innovative service delivery model, supported by the researchers, yet trained and empowered to implement the clinical service throughout the trial period and beyond. The balance between support and independence appeared crucial in the pharmacists’ engagement with the trial. Their feedback was overwhelmingly positive, while useful suggestions were identified for future academic trials. 2012 Journal Article http://hdl.handle.net/20.500.11937/33002 10.1186/1472-6963-12-164 BioMed Central fulltext
spellingShingle Emmerton, Lynne
Smith, L.
LeMay, K.
Krass, I.
Saini, B.
Bosnic-Anticevich, S.
Reddel, H.
Burton, D.
Stewart, Kay
Armour, C.
Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title_full Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title_fullStr Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title_full_unstemmed Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title_short Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia
title_sort experiences of community pharmacists involved in the delivery of a specialist asthma service in australia
url http://hdl.handle.net/20.500.11937/33002